Clinicians are increasingly turning to intestinal ultrasound (IUS) as a way to monitor inflammatory bowel disease (IBD) without the bowel preparation, sedation, or recovery time required for colonoscopy. A recent report highlights how this point-of-care imaging technique is being adopted more widely in gastroenterology clinics to track disease activity in Crohn’s disease and ulcerative colitis.
Background
Monitoring IBD effectively means looking beyond symptoms alone, since inflammation can persist even when a patient feels well. Clinicians have traditionally relied on colonoscopy, blood tests, and faecal calprotectin to assess disease activity and guide treatment decisions. Colonoscopy remains the reference standard for visualising the bowel lining directly, but it requires laxative preparation, sedation, and a recovery period, making frequent use impractical for many patients. As IBD care increasingly follows a “treat to target” approach, in which treatment is adjusted based on objective evidence of inflammation rather than symptoms alone, there is growing interest in tools that allow more frequent, lower-burden reassessment.
Key Findings
According to the report, IUS allows clinicians to visualise the bowel wall in real time using a handheld probe placed on the abdomen, with no prior preparation or sedation needed. The scan can be performed during a routine outpatient appointment and results are available immediately, allowing clinicians to adjust management decisions during the same visit rather than waiting for a separate procedure or test results. The technique can identify bowel wall thickening, increased blood flow around inflamed segments, and complications such as strictures or fistulas, all of which are markers used to assess disease severity and treatment response. Because it avoids radiation exposure, unlike computed tomography, and can be repeated as often as clinically needed, the report describes IUS as particularly well suited to monitoring patients over time, including tracking how well a treatment is working after it has started. It is described as complementing rather than replacing colonoscopy, which remains necessary for detailed mucosal assessment and biopsy.
Clinical Relevance
For people living with Crohn’s disease or ulcerative colitis, reducing the frequency of invasive procedures while still allowing close monitoring could ease the physical and logistical burden of long-term disease management. For gastroenterologists and IBD nurses, a same-visit imaging tool that provides immediate feedback may support faster, more responsive treatment adjustments in line with treat-to-target strategies. The report frames this as a shift in how monitoring can be delivered in practice, rather than a change to any specific drug or treatment protocol, and notes that wider adoption will depend on training and access to the appropriate equipment across different clinical settings.
Reference
The material provided for this article was a secondary news report (Yahoo Health, “No Prep, No Anesthesia: Why Intestinal Ultrasound Is the New Frontier of IBD Monitoring”) and did not identify or link to a specific underlying peer-reviewed study, trial, or guideline. As no primary source could be verified from the material supplied, this summary is attributed to that report rather than to an original research publication.
This article is a journalistic summary for informational purposes only. It does not constitute clinical advice or a recommendation to alter treatment decisions.